TuHURA Biosciences, Inc. Common Stock

HURANASDAQUSD
2.26 USD
0.09 (3.83%)AT CLOSE (11:59 AM EDT)
2.36
0.10 (4.20%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
2.36
0.10 (4.20%)
🔴Market: CLOSED
Open?$2.34
High?$2.35
Low?$2.21
Prev. Close?$2.35
Volume?468.7K
Avg. Volume?738.3K
VWAP?$2.26
Rel. Volume?0.63x
Bid / Ask
Bid?$2.32 × 1.3K
Ask?$2.39 × 900
Spread?$0.07
Midpoint?$2.36
Valuation & Ratios
Market Cap?143.9M
Shares Out?N/A
Float?32.2M
Float %?53.0%
P/E Ratio?N/A
P/B Ratio?6.21
EPS?-$0.49
Dividend?0.01%
Ex-Dividend?N/A

TuHURA Biosciences, Inc. Common Stock (HURA) is currently trading at $2.26. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. HURA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of May 29, 2026.

News
Profile
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Employees
22
Market Cap
143.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-10-18
Address
10500 UNIVERSITY CENTER DR.
TAMPA, FL 33612
Phone: 813-875-6600
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
61
Momentum?
50
Short Sent.?
39
Piotroski F-Score?0/9Weak
Altman Z-Score?2.69Grey
Confidence?45%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?24.83%Squeeze Risk
Short Interest?8.0M
Days to Cover?13.8
Free Float32.2M
Avg Daily Volume578.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?1.15Adequate
Quick Ratio?1.15Adequate
Cash Ratio?1.04Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
30
6.21FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-4.8CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-133.4%WEAK
ROA?
S&P
3
-104.1%WEAK
Cash Flow & Enterprise
FCF?$-27385938
Enterprise Value?$137.6M
Fundamentals ratios updated end of day